To test the effect of combinatorial Wnt and MEK inhibition in vivo, we established a PDX model by subcutaneous engraftment of CRC organoids into immunodeficient gamma NOD/SCID mice. The gene discussed is MAP2K7; the disease is colorectal carcinoma.